Cargando…
Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report
BACKGROUND: Male breast cancer (MBC) is rare, accounting for only around 1% of all breast cancers. Most MBCs are hormone-driven. Not only the estrogen receptor (ER), but also other steroid hormone receptors, including the androgen receptor (AR) and progesterone receptor (PgR) are expressed in MBC. A...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303965/ https://www.ncbi.nlm.nih.gov/pubmed/30577860 http://dx.doi.org/10.1186/s12885-018-5216-6 |